699 related articles for article (PubMed ID: 27614379)
1. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
4. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
5. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
6. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
9. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
[TBL] [Abstract][Full Text] [Related]
10. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
[TBL] [Abstract][Full Text] [Related]
11. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
[TBL] [Abstract][Full Text] [Related]
12. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
Thiele H; Kurz T; Feistritzer HJ; Stachel G; Hartung P; Eitel I; Marquetand C; Nef H; Doerr O; Lauten A; Landmesser U; Abdel-Wahab M; Sandri M; Holzhey D; Borger M; Ince H; Öner A; Meyer-Saraei R; Wienbergen H; Fach A; Frey N; König IR; Vonthein R; Rückert Y; Funkat AK; de Waha-Thiele S; Desch S
Eur Heart J; 2020 May; 41(20):1890-1899. PubMed ID: 32049283
[TBL] [Abstract][Full Text] [Related]
13. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
[TBL] [Abstract][Full Text] [Related]
14. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
15. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
16. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
[TBL] [Abstract][Full Text] [Related]
17. Successful transapical implantation of an Edwards Sapien valve within an insufficient aortic CoreValve prosthesis: an initial experience.
Schleger S; Kasel M; Vogel J; Lieber M; Antoni D; Hoffmann E; Eichinger WB
Ann Thorac Surg; 2013 Mar; 95(3):1070-2. PubMed ID: 23438533
[TBL] [Abstract][Full Text] [Related]
18. Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience.
Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W
PLoS One; 2016; 11(3):e0151247. PubMed ID: 27003573
[TBL] [Abstract][Full Text] [Related]
19. Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation.
Marzahn C; Koban C; Seifert M; Isotani A; Neuß M; Hölschermann F; Butter C
J Cardiol; 2018 Jan; 71(1):101-108. PubMed ID: 28818562
[TBL] [Abstract][Full Text] [Related]
20. The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre- and postinterventional cardiac computed tomography angiography study.
Bekeredjian R; Bodingbauer D; Hofmann NP; Greiner S; Schuetz M; Geis NA; Kauczor HU; Bryant M; Chorianopoulos E; Pleger ST; Mereles D; Katus HA; Korosoglou G
J Invasive Cardiol; 2015 Mar; 27(3):172-80. PubMed ID: 25740972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]